GUARDANT HEALTH, INC. (GH) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | (m) | |
| Revenue | 1.18B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 413.95M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | (m) | $1.18B | $413.95M | (m) |
| 2026-03-31 | (m) | $1.08B | $379.20M | (m) |
| 2025-12-31 | (m) | $982.02M | $349.01M | (m) |
| 2025-09-30 | (m) | $902.57M | (m) | (m) |
| 2025-06-30 | (m) | $828.85M | (m) | (m) |
| 2025-03-31 | (m) | $774.00M | (m) | (m) |
| 2024-12-31 | (m) | $739.02M | (m) | (m) |
| 2024-09-30 | (m) | $692.26M | (m) | (m) |
| 2024-06-30 | (m) | $643.81M | (m) | (m) |
| 2024-03-31 | (m) | $603.73M | (m) | (m) |
| 2023-12-31 | (m) | $563.95M | (m) | (m) |
| 2023-09-30 | (m) | $535.78M | (m) | (m) |
| 2023-06-30 | (m) | $510.16M | (m) | (m) |
| 2023-03-31 | (m) | $482.15M | (m) | (m) |
| 2022-12-31 | (m) | $449.54M | (m) | (m) |
| 2022-09-30 | (m) | $430.75M | (m) | (m) |
| 2022-06-30 | (m) | $408.13M | (m) | (m) |
| 2022-03-31 | (m) | $391.09M | (m) | (m) |
| 2021-12-31 | (m) | $373.65M | (m) | (m) |
| 2021-09-30 | (m) | $343.86M | (m) | (m) |
| 2021-06-30 | (m) | $323.65M | (m) | (m) |
| 2021-03-31 | (m) | $297.88M | (m) | (m) |
| 2020-12-31 | (m) | $286.73M | (m) | (m) |
| 2020-09-30 | (m) | $271.31M | (m) | (m) |
| 2020-06-30 | (m) | $257.59M | (m) | (m) |
| 2020-03-31 | (m) | $245.23M | (m) | (m) |
| 2019-12-31 | (m) | $214.38M | (m) | (m) |
| 2019-09-30 | (m) | $184.35M | (m) | (m) |
| 2019-06-30 | (m) | $145.19M | (m) | (m) |
| 2019-03-31 | (m) | $110.60M | (m) | (m) |
| 2018-12-31 | (m) | $90.64M | (m) | (m) |
| 2018-09-30 | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $49.84M | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $25.25M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |